Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1174
4.890
 Why?
Early Detection of Cancer
6
2020
169
2.450
 Why?
Ultrasonography, Mammary
8
2020
60
2.110
 Why?
Colorectal Neoplasms
4
2018
236
1.590
 Why?
Mass Screening
3
2020
353
1.550
 Why?
Healthcare Disparities
3
2017
257
1.150
 Why?
Mastectomy
13
2019
140
1.120
 Why?
Mastectomy, Segmental
7
2018
92
1.100
 Why?
Sentinel Lymph Node Biopsy
10
2015
116
1.040
 Why?
Community Health Planning
3
2018
28
1.020
 Why?
Ultrasonography, Interventional
5
2020
136
0.870
 Why?
Biopsy, Needle
10
2015
183
0.860
 Why?
Focus Groups
1
2024
190
0.860
 Why?
Biopsy, Large-Core Needle
3
2020
31
0.840
 Why?
Neoplasm Staging
14
2024
740
0.840
 Why?
Female
55
2024
26472
0.810
 Why?
Genetic Counseling
1
2022
38
0.790
 Why?
Health Status Disparities
3
2015
195
0.780
 Why?
Neoplasms
5
2015
1235
0.780
 Why?
Lymph Nodes
7
2015
260
0.770
 Why?
Patient Education as Topic
1
2024
302
0.750
 Why?
Image Interpretation, Computer-Assisted
1
2020
106
0.700
 Why?
Middle Aged
40
2024
12069
0.690
 Why?
Image-Guided Biopsy
2
2020
33
0.680
 Why?
Hematoma
4
2018
64
0.670
 Why?
Surgery, Computer-Assisted
2
2018
55
0.660
 Why?
Polymorphism, Single Nucleotide
2
2018
485
0.640
 Why?
Humans
60
2024
49974
0.630
 Why?
Mandatory Programs
1
2018
23
0.620
 Why?
Adiposity
1
2019
127
0.600
 Why?
Faculty, Medical
3
2021
89
0.600
 Why?
Health Care Costs
1
2018
170
0.580
 Why?
Aged
31
2024
9310
0.580
 Why?
Adult
32
2024
13236
0.580
 Why?
Insurance Coverage
1
2018
103
0.570
 Why?
Disease Management
1
2018
174
0.550
 Why?
Diagnostic Imaging
1
2018
176
0.540
 Why?
Minority Groups
3
2015
132
0.530
 Why?
Arkansas
9
2018
1977
0.520
 Why?
Retrospective Studies
19
2022
6108
0.490
 Why?
Physicians
1
2018
233
0.480
 Why?
Health Planning Councils
1
2014
6
0.470
 Why?
Community-Based Participatory Research
2
2015
199
0.450
 Why?
Health Policy
1
2014
153
0.430
 Why?
Rural Population
1
2017
540
0.430
 Why?
Follow-Up Studies
11
2018
2182
0.420
 Why?
Aged, 80 and over
14
2018
3129
0.410
 Why?
Qualitative Research
3
2024
329
0.410
 Why?
Community Networks
2
2015
50
0.400
 Why?
Community-Institutional Relations
1
2011
46
0.400
 Why?
Primary Health Care
2
2024
358
0.390
 Why?
Carcinoma, Lobular
2
2015
33
0.380
 Why?
Carcinoma, Ductal, Breast
4
2015
89
0.380
 Why?
Population Surveillance
1
2012
164
0.370
 Why?
Physicians, Women
2
2021
22
0.370
 Why?
Neoplasm Recurrence, Local
6
2014
614
0.350
 Why?
Women's Health
1
2010
90
0.340
 Why?
Needs Assessment
2
2024
133
0.340
 Why?
Health Education
2
2008
156
0.340
 Why?
Medical Oncology
1
2010
94
0.330
 Why?
Breast Diseases
4
2018
26
0.320
 Why?
Nipples
5
2013
33
0.300
 Why?
Schools, Medical
2
2020
69
0.300
 Why?
Axilla
6
2015
89
0.300
 Why?
Health Knowledge, Attitudes, Practice
1
2012
488
0.300
 Why?
Socioeconomic Factors
3
2018
581
0.290
 Why?
Morbidity
2
2018
133
0.290
 Why?
Health Services Accessibility
1
2011
398
0.280
 Why?
Physician-Patient Relations
2
2012
140
0.280
 Why?
Catheter Ablation
4
2014
123
0.260
 Why?
Mammaplasty
3
2013
42
0.260
 Why?
Prognosis
9
2024
1942
0.260
 Why?
Mentors
1
2006
55
0.260
 Why?
Lymphatic Metastasis
7
2015
224
0.260
 Why?
Survivors
2
2024
126
0.250
 Why?
Occult Blood
2
2017
22
0.250
 Why?
United States
7
2022
4860
0.240
 Why?
Young Adult
5
2024
3958
0.240
 Why?
Magnetic Resonance Imaging
5
2014
1537
0.230
 Why?
Referral and Consultation
2
2024
285
0.220
 Why?
Education, Medical, Graduate
2
2022
205
0.220
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.210
 Why?
Male
13
2022
25241
0.210
 Why?
Empathy
1
2002
46
0.200
 Why?
Problem-Based Learning
1
2002
47
0.200
 Why?
Atrial Fibrillation
1
2024
180
0.200
 Why?
Emotions
1
2023
165
0.200
 Why?
Breast
2
2020
85
0.190
 Why?
Democratic Republic of the Congo
1
2020
4
0.190
 Why?
Genetic Testing
1
2022
119
0.190
 Why?
Dermatologic Surgical Procedures
3
2013
34
0.190
 Why?
Counseling
1
2022
132
0.190
 Why?
Feasibility Studies
2
2020
375
0.190
 Why?
Combined Modality Therapy
4
2018
637
0.190
 Why?
Biopsy, Fine-Needle
1
2020
103
0.180
 Why?
Research Support as Topic
1
2020
46
0.180
 Why?
Students, Medical
1
2002
157
0.170
 Why?
General Surgery
1
2021
105
0.170
 Why?
Surgical Flaps
2
2019
119
0.170
 Why?
Obesity
1
2008
1113
0.170
 Why?
Prospective Studies
10
2024
2364
0.170
 Why?
Incidence
2
2024
1003
0.160
 Why?
Patient Satisfaction
2
2019
273
0.160
 Why?
Radiopharmaceuticals
4
2008
209
0.150
 Why?
Adipose Tissue
1
2019
187
0.150
 Why?
Logistic Models
2
2018
888
0.150
 Why?
Diagnosis, Differential
1
2020
1037
0.140
 Why?
Lymphatic Vessels
2
2008
48
0.140
 Why?
Rural Health
1
2017
87
0.140
 Why?
Odds Ratio
1
2018
545
0.140
 Why?
Zambia
3
2024
3
0.140
 Why?
Internship and Residency
1
2022
443
0.140
 Why?
Mammography
1
2016
96
0.130
 Why?
Rural Health Services
1
2018
166
0.130
 Why?
Cytodiagnosis
2
2013
42
0.130
 Why?
Genetic Predisposition to Disease
1
2018
510
0.130
 Why?
Case-Control Studies
1
2018
1131
0.130
 Why?
Cross-Sectional Studies
3
2021
1557
0.130
 Why?
Risk Assessment
2
2018
1259
0.130
 Why?
National Cancer Institute (U.S.)
1
2015
32
0.120
 Why?
Survival Rate
1
2017
894
0.120
 Why?
Uterine Cervical Neoplasms
1
2017
277
0.120
 Why?
Algorithms
1
2018
615
0.120
 Why?
Career Mobility
2
2021
25
0.120
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
42
0.110
 Why?
Monitoring, Intraoperative
3
2014
54
0.110
 Why?
Education, Medical
2
2006
112
0.110
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
18
0.100
 Why?
Health Services
1
2012
67
0.100
 Why?
Colonoscopy
1
2012
93
0.100
 Why?
Lymph Node Excision
4
2008
134
0.100
 Why?
Feces
1
2012
134
0.100
 Why?
Reproducibility of Results
1
2015
1193
0.100
 Why?
Treatment Outcome
9
2017
5141
0.100
 Why?
Receptors, Estrogen
2
2015
130
0.090
 Why?
Lymphedema
2
2008
43
0.090
 Why?
Pancreatic Neoplasms
1
2013
208
0.090
 Why?
Fructose
1
2010
23
0.090
 Why?
Clinical Competence
1
2013
393
0.090
 Why?
Registries
1
2013
522
0.090
 Why?
Patient Compliance
1
2012
230
0.090
 Why?
Carbon
1
2010
54
0.090
 Why?
History, 21st Century
1
2010
56
0.090
 Why?
Risk Factors
3
2024
3613
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
989
0.080
 Why?
Carcinoma in Situ
2
2006
73
0.080
 Why?
Patient Acceptance of Health Care
1
2012
329
0.080
 Why?
Delivery of Health Care
1
2011
309
0.080
 Why?
Models, Theoretical
2
2006
175
0.070
 Why?
Prochlorperazine
1
2006
6
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.070
 Why?
Sensitivity and Specificity
3
2004
861
0.070
 Why?
Education, Medical, Continuing
1
2006
68
0.070
 Why?
Antiemetics
1
2006
32
0.070
 Why?
Receptor, erbB-2
1
2006
73
0.070
 Why?
Body Weights and Measures
1
2005
17
0.070
 Why?
Predictive Value of Tests
2
2013
903
0.070
 Why?
Biopsy
2
2004
584
0.060
 Why?
Intraoperative Care
2
2003
54
0.060
 Why?
Gadolinium
1
2005
43
0.060
 Why?
Interprofessional Relations
1
2006
85
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neoadjuvant Therapy
2
2017
114
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Botulinum Toxins, Type A
1
2004
13
0.060
 Why?
Imaging, Three-Dimensional
1
2005
151
0.060
 Why?
Life Expectancy
1
2024
34
0.060
 Why?
Contrast Media
1
2005
184
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Anthracyclines
1
2024
27
0.060
 Why?
Pain, Postoperative
1
2004
158
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
43
0.060
 Why?
Neoplasm Grading
2
2014
123
0.060
 Why?
Preoperative Care
3
2014
164
0.050
 Why?
Surgical Instruments
1
2002
28
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Life Change Events
1
2002
35
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Confidence Intervals
1
2002
156
0.050
 Why?
Career Choice
1
2002
111
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Program Development
1
2002
166
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
242
0.050
 Why?
Leadership
1
2021
101
0.040
 Why?
Neoplasm Invasiveness
2
2010
267
0.040
 Why?
Vacuum
2
2011
13
0.040
 Why?
Curriculum
1
2002
401
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
43
0.040
 Why?
Gene Frequency
1
2017
94
0.040
 Why?
Injections, Intralesional
2
2008
31
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Adolescent
3
2013
6356
0.030
 Why?
Guidelines as Topic
1
2016
111
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
201
0.030
 Why?
Regression Analysis
1
2017
395
0.030
 Why?
Coloring Agents
2
2007
69
0.030
 Why?
Neovascularization, Pathologic
1
2017
161
0.030
 Why?
Radionuclide Imaging
2
2007
116
0.030
 Why?
Educational Status
1
2016
222
0.030
 Why?
Genotype
1
2017
537
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
63
0.030
 Why?
Cohort Studies
2
2011
1422
0.030
 Why?
Cyclophosphamide
1
2015
165
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Ultrasonography, Doppler
1
2014
42
0.030
 Why?
Carcinoma
1
2015
138
0.030
 Why?
Angiogenesis Inhibitors
1
2015
187
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
 Why?
Disease-Free Survival
1
2014
454
0.030
 Why?
Kaplan-Meier Estimate
1
2014
466
0.030
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
11
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
100
0.020
 Why?
Substrate Specificity
1
2010
194
0.020
 Why?
Actins
1
2010
118
0.020
 Why?
Tumor Cells, Cultured
1
2010
465
0.020
 Why?
Cell Movement
1
2010
247
0.020
 Why?
Breast Neoplasms, Male
1
2009
6
0.020
 Why?
Pilot Projects
1
2011
699
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
729
0.020
 Why?
Cost-Benefit Analysis
1
2008
274
0.020
 Why?
Administration, Rectal
1
2006
11
0.020
 Why?
Positron-Emission Tomography
1
2008
295
0.020
 Why?
Cell Line, Tumor
1
2010
1403
0.020
 Why?
Probability
1
2006
164
0.020
 Why?
Primary Prevention
1
2006
44
0.020
 Why?
Drug Administration Schedule
1
2006
376
0.020
 Why?
Administration, Oral
1
2006
426
0.020
 Why?
Carcinoma, Ductal
1
2004
9
0.020
 Why?
Tissue Expansion
1
2004
4
0.020
 Why?
Pectoralis Muscles
1
2004
6
0.020
 Why?
Rectus Abdominis
1
2004
7
0.020
 Why?
Spasm
1
2004
9
0.020
 Why?
Laser Coagulation
1
2004
26
0.020
 Why?
Multivariate Analysis
1
2006
577
0.020
 Why?
Cryosurgery
1
2004
36
0.020
 Why?
Sampling Studies
1
2004
37
0.020
 Why?
Statistics, Nonparametric
1
2004
194
0.010
 Why?
Chi-Square Distribution
1
2004
280
0.010
 Why?
Injections
1
2003
55
0.010
 Why?
Pain Measurement
1
2004
240
0.010
 Why?
Ultrasonography
1
2004
436
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1376
0.010
 Why?
Length of Stay
1
2004
619
0.010
 Why?
Reoperation
1
2002
454
0.010
 Why?
Analgesics, Opioid
1
2004
552
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department